This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dbaibo, G. S. Articles by Bazarbachi, A. Search for Related Content PubMed PubMed Citation Articles by Dbaibo, G. S. Articles by Bazarbachi, A.

Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity

From the Departments of Pediatrics (GSD, SP, LK), Internal Medicine (YK, RN, MA, AB), Biology (ND), and Human Morphology, American University of Beirut, Beirut, Lebanon (ME-S); CNRS UMR 8603 and Department of Hematology, Necker Hospital, Paris, France (OH); UMR 7151 CNRS/University of Paris 7, France (HdT)

Correspondence: Ali Bazarbachi, MD, Ph.D. Department of Internal Medicine, American University of Beirut. PO Box 113-6044, Beirut, Lebanon. E-mail: bazarbac{at}aub.edu.lb

Background and Objectives: Arsenic trioxide (ATO) is an effective treatment for acute promyelocytic leukemia (APL) and potentially for human T-cell leukemia virus type I (HTLV-I) associated adult T-cell leukemia/lymphoma (ATL). Many cytotoxic drugs induce apoptosis through the generation and accumulation of the sphingolipid breakdown product, ceramide, a coordinator of the cellular response to stress. We, therefore, investigated the contribution of ceramide to the mechanism of action of ATO in APL and ATL.

Design and Methods: A human APL-derived cell line (NB4), various ATL-derived lines and an HTLV-I-negative malignant T-cell line were cultured and treated with ATO. Growth and apoptosis assays were conducted. Measurements were made of ceramide, diacylglycerol, sphingomyelinase activity, sphingomyelin mass, glucosylceramide synthase activity and the de novo ceramide synthesis.

Results: Treatment of APL and ATL-derived cells with a clinically achievable concentration of ATO induced accumulation of cytotoxic levels of ceramide. The effects of ATO on ceramide levels in APL cells were more potent than those of all-trans retinoic acid (ATRA). ATO downregulated neutral sphingomyelinase activity. In contrast to the effect of ATRA, ATO-induced ceramide accumulation was not due to induction of acidic sphingomyelinase, but rather resulted from both de novo ceramide synthesis and inhibition of glucosylceramide synthase activity. Interestingly, the effects of ATO on de novo ceramide synthesis were similar in APL and ATL-derived cells despite the defective pathway in ATL cells.

Interpretation and Conclusions: These results indicate that ATO-induced ceramide accumulation may represent a general mediator of the effects of ATO, which paves the way for new therapeutic interventions that target the metabolic pathway of this important sphingolipid secondary messenger.

Key words: arsenic trioxide, acute promyelocytic leukemia, adult T-cell leukemia/lymphoma, ceramide synthesis, glycosylceramide synthase.

This article has been cited by other articles:

				M.-O. Chandesris, D. Ghez, C. Besson, F. Suarez, R. Delarue, M.-T. Rubio, A. Bazarbachi, B. Varet, and O. Hermine Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid? BMJ Case Reports, August 10, 2009; 2009(aug10_1): bcr0120091449 - bcr0120091449. [Abstract] [Full Text]

				K. Gustafsson, B. Sander, J. Bielawski, Y. A. Hannun, and J. Flygare Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism Mol. Cancer Res., July 1, 2009; 7(7): 1086 - 1098. [Abstract] [Full Text] [PDF]

				S. Jin, F. Yi, F. Zhang, J. L. Poklis, and P.-L. Li Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 2056 - 2062. [Abstract] [Full Text] [PDF]